Marshall Wace, LLP Agios Pharmaceuticals, Inc. Transaction History

Marshall Wace, LLP

$90.8 Billion
Q3 2025

A detailed history of Marshall Wace, LLP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 226,824 shares of AGIO stock, worth $9.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

226,824

Previous 684,669 66.87%

Holding current value

$9.9 Million

Previous $22.8 Million 60.02%

% of portfolio

0.01%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$34.37 - $40.61 $15.7 Million - $18.6 Million	-457,845 Reduced 66.87%	226,824 $9.1 Million
Q2 2025 Aug 13, 2025	BUY	$24.53 - $35.75 $4.02 Million - $5.86 Million	163,796 Added 31.45%	684,669 $22.8 Million
Q1 2025 May 15, 2025	SELL	$29.3 - $35.9 $3.25 Million - $3.98 Million	-110,755 Reduced 17.53%	520,873 $15.3 Million
Q4 2024 Feb 13, 2025	SELL	$32.86 - $61.64 $20.8 Million - $38.9 Million	-631,657 Reduced 50.0%	631,628 $20.8 Million
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $5.34 Million - $6.44 Million	129,550 Added 11.43%	1,263,285 $56.1 Million

Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $23.6 Million - $41.8 Million	855,739 Added 307.82%	1,133,735 $48.9 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $5.93 Million - $9.68 Million	277,996 New	277,996 $8.13 Million
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $1.41 Million - $1.64 Million	58,040 New	58,040 $1.44 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $568,716 - $995,181	-29,150 Reduced 66.91%	14,413 $408,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $743,184 - $1.37 Million	43,563 New	43,563 $966,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $389,021 - $507,564	-14,581 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $431,305 - $725,842	14,581 New	14,581 $479,000
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $1.94 Million - $2.52 Million	-43,878 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $142,304 - $199,423	4,285 Added 10.82%	43,878 $1.9 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $1.34 Million - $2.21 Million	39,593 New	39,593 $1.39 Million
Q2 2020 Aug 13, 2020	SELL	$34.45 - $53.48 $1.9 Million - $2.95 Million	-55,234 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $3.77 Million - $6.43 Million	-119,501 Reduced 68.39%	55,234 $1.96 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $3.11 Million - $5.23 Million	103,475 Added 145.21%	174,735 $8.34 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $2.31 Million - $3.53 Million	71,260 New	71,260 $2.31 Million
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $170,684 - $251,529	-3,717 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $158,827 - $284,462	3,717 New	3,717 $171,000
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $393,468 - $504,805	-5,490 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $198,865 - $270,377	2,716 Added 97.91%	5,490 $462,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $165,968 - $240,034	2,774 New	2,774 $227,000
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $499,674 - $693,427	-9,587 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $526,230 - $643,479	9,587	9,587 $642,000

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.39B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Agios Pharmaceuticals, Inc. Transaction History